Literature DB >> 1433038

A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle.

R Smith1, J W Studd.   

Abstract

A questionnaire enquiring about changes in severity of symptoms of multiple sclerosis with the menstrual cycle, menopause and use of hormone replacement therapy was answered retrospectively by 11 premenopausal and 19 postmenopausal women. Eighty-two per cent of menopausal women reported an increase in severity premenstrually. Of the postmenopausal women 54% reported a worsening of symptoms with the menopause, and 75% of those who had tried hormone replacement therapy reported an improvement. The results of this pilot study indicate the need for further research to clarify the effects of the menopause and hormone replacement therapy upon multiple sclerosis.

Entities:  

Mesh:

Year:  1992        PMID: 1433038      PMCID: PMC1293688          DOI: 10.1177/014107689208501008

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  12 in total

1.  FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1965-07       Impact factor: 9.910

2.  Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding.

Authors:  L M Nelson; G M Franklin; M C Jones
Journal:  JAMA       Date:  1988-06-17       Impact factor: 56.272

3.  The menopausal syndrome.

Authors:  S M McKinlay; M Jefferys
Journal:  Br J Prev Soc Med       Date:  1974-05

4.  Long-term effects of the menopause and sex hormones on skin thickness.

Authors:  M Brincat; C J Moniz; J W Studd; A Darby; A Magos; G Emburey; E Versi
Journal:  Br J Obstet Gynaecol       Date:  1985-03

5.  The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario.

Authors:  B G Weinshenker; W Hader; W Carriere; J Baskerville; G C Ebers
Journal:  Neurology       Date:  1989-11       Impact factor: 9.910

6.  Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy.

Authors:  V Sridama; F Pacini; S L Yang; A Moawad; M Reilly; L J DeGroot
Journal:  N Engl J Med       Date:  1982-08-05       Impact factor: 91.245

7.  Effects of the menstrual cycle on medical disorders.

Authors:  A Magos; J Studd
Journal:  Br J Hosp Med       Date:  1985-02

8.  Effect of 17 beta-oestradiol on lymphocyte subpopulations, delayed cutaneous hypersensitivity responses and mixed lymphocyte reactions in post-menopausal women.

Authors:  I T Manyonda; R S Pereira; V Makinde; M Brincat; R T Varma
Journal:  Maturitas       Date:  1992-03       Impact factor: 4.342

9.  The effects of pregnancy in multiple sclerosis: a retrospective study.

Authors:  D S Thompson; L M Nelson; A Burns; J S Burks; G M Franklin
Journal:  Neurology       Date:  1986-08       Impact factor: 9.910

10.  Activity of multiple sclerosis during pregnancy and puerperium.

Authors:  I Korn-Lubetzki; E Kahana; G Cooper; O Abramsky
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

View more
  17 in total

Review 1.  Menopause in multiple sclerosis: therapeutic considerations.

Authors:  Riley Bove; Tanuja Chitnis; Maria Houtchens
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

Review 2.  The importance of studying sex differences in disease: The example of multiple sclerosis.

Authors:  Lisa C Golden; Rhonda Voskuhl
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 3.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

Review 4.  Gender issues and multiple sclerosis.

Authors:  Rhonda R Voskuhl
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 5.  Autoimmune diseases and reproductive aging.

Authors:  Riley Bove
Journal:  Clin Immunol       Date:  2013-02-28       Impact factor: 3.969

6.  Increased mortality for neurological and mental diseases following early bilateral oophorectomy.

Authors:  Cathleen M Rivera; Brandon R Grossardt; Deborah J Rhodes; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2009-04-08       Impact factor: 3.282

7.  Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.

Authors:  Riley Bove; Brian C Healy; Alexander Musallam; Bonnie I Glanz; Philip L De Jager; Tanuja Chitnis
Journal:  Mult Scler       Date:  2015-10-07       Impact factor: 6.312

Review 8.  Multiple sclerosis management and reproductive changes: A guide for general neurologists.

Authors:  Marwa Kaisey; Nancy Sicotte; Barbara Giesser
Journal:  Neurol Clin Pract       Date:  2018-04

Review 9.  Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review.

Authors:  Riley Bove; Annette Okai; Maria Houtchens; Birte Elias-Hamp; Alessandra Lugaresi; Kerstin Hellwig; Eva Kubala Havrdová
Journal:  Front Neurol       Date:  2021-03-19       Impact factor: 4.003

Review 10.  Gender and sex hormones in multiple sclerosis pathology and therapy.

Authors:  Arnaud Nicot
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.